Fenofibrate Raw Material Fenofibrate Powder

CAS: 49562-28-9

MF: C20H21ClO4

MW:360.83

EINECS: 256-376-3

Specification​: 99% min Fenofibrate 

Sample: Fenofibrate Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Fenofibrate Raw Materials Usage and Synthesis

Manufactory Supply Fenofibrate Raw Material, High Purity 99% Fenofibrate Powder CAS 49562-28-9 Fenofibrate Raw Powder.Butenafine Raw Powder is one of the drugs of choice for lowering triglycerides, Butenafine Powder also reduces blood uric acid levels and has a better effect on the treatment of type 2 diabetes mellitus and metabolic syndrome, which has a good market prospect.

Uses and functions of Fenofibrate Powder

Butenafine Raw Powder contains phenoxyacetic acid, p-chlorobenzoyl, isopropyl ester, with slightly greater fat solubility; precursor drug, metabolised in vivo to fenofibrate acid to play a role in lowering blood lipids; Fenofibrate Powder is clinically used for the treatment of hyperlipidaemia, especially high triacylglycerolaemia, mixed hyperlipidaemia.

Pharmacological Effects of Fenofibrate Raw Powder

• 1.Lipotropic effect Fenofibrate can reduce the total triglyceride (TG) level by 25% to 59%, increase the level of high-density lipoprotein-cholesterol (HDL-C) by 1% to 34%, and decrease the level of total cholesterol (TC) by 6% to 27%, and it is clinically used for the treatment of TG elevation or mixed hyperlipidaemia with predominantly elevated TG and hyperlipidaemia with low HDL-C.
• Fenofibrate Raw Powder is significantly better than statins in its efficacy in lowering TG and elevating HDL-C. Since simple dyslipidemia is relatively rare in diabetic patients, whose common lipid profile is increased TC, decreased HDL-C, and elevated or normal low-density lipoprotein-cholesterol (LDL-C), fenofibrate is used in the treatment of dyslipidemia in diabetic patients with Clinical efficacy is significant.

• In addition, fenofibrate has a different mechanism of action from that of statins, which can significantly reduce TC and LDL-C, and the combination of these two drugs can form a complementary therapeutic effect.
• Therefore, Fenofibrate Raw Powder can be used in combination with atorvastatin, simvastatin and other statins to adjust the lipid profile of patients with mixed hyperlipidaemia.

Production method of Raw Fenofibrate Powder

May enhance the effect of warfarin and other anticoagulants, when taking anticoagulants at the same time, should be tested for coagulation indicators, pay attention to adjust the dose. Be careful when taking Fenofibrate with other cholesterol-lowering drugs (other fibrates, statins). Uses Fenofibrate is used as a hypolipidemic drug.